IPP Bureau
Thermo Fisher Scientific introduces On the Go mobile app in India
By IPP Bureau - October 07, 2021
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
WHO gives its go-ahead for first-ever malaria vaccine
By IPP Bureau - October 07, 2021
It recommends using the vaccine to prevent the spread of the disease
Twin Health raises US $ 140 million in Series C funding
By IPP Bureau - October 07, 2021
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
Moderna to build mRNA facility in Africa
By IPP Bureau - October 07, 2021
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Janssen announces novel mechanism that shows promise against dengue
By IPP Bureau - October 07, 2021
Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats
U.S. FDA clears Venclose Maven to treat incompetent perforator veins
By IPP Bureau - October 07, 2021
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
PM Modi dedicates 35 oxygen plants to the nation
By IPP Bureau - October 07, 2021
Now all districts of the country will have commissioned PSA Oxygen plants
PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel
By IPP Bureau - October 07, 2021
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D
By IPP Bureau - October 06, 2021
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
WHO decision on Covaxin approval next week
By IPP Bureau - October 06, 2021
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
.jpg "IPM growth led by Covid driven products to taper off in Q2FY22: Nirmal Bang")
IPM growth led by Covid driven products to taper off in Q2FY22: Nirmal Bang
By IPP Bureau - October 06, 2021
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
Lupin receives tentative approval for Brexpiprazole tablets
By IPP Bureau - October 06, 2021
This product will be manufactured at Lupin’s Pithampur facility In India
EMA authorises booster dose of Moderna’s Spikevax
By IPP Bureau - October 06, 2021
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
Ayushman Bharat PM-JAY rates revised
By IPP Bureau - October 06, 2021
The rates for over 400 procedures were revised
Paediatric healthcare platform Health Basix raises seed fund
By IPP Bureau - October 06, 2021
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
